Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated the safety and tolerability of immunotherapy combinations across multiple advanced cancers and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Castration-resistant Prostate Cancer
• Colorectal Cancer
• Melanoma
• Non-small Cell Lung Cancer
• Ovarian Cancer
• Renal Cell Carcinoma
• Squamous Cell Carcinoma of the Head and Neck

Snippet

Sponsor: Arcus Biosciences, Inc. | Conditions: Non-small Cell Lung Cancer, Squamous Cell Carcinoma of the Head and Neck | Phase 1 | Status: COMPLETED